This report provides comprehensive information on the current therapeutic developmental pipeline of FIT Biotech Oyjs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get Detail Report With TOC @ http://www.researchmoz.us/fit-biotech-oyj-product-pipeline-review-2014-report.html The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. FIT Biotech Oyj - Product Pipeline Review - 2014
FIT Biotech Oyj - Product Pipeline Review - 2014
Summary
Global Markets Directs, FIT Biotech Oyj - Product Pipeline Review - 2014, provides an overview of the FIT Biotech Oyjs pharmaceutical research and
development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of FIT Biotech Oyjs, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest
updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of FIT Biotech Oyj including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of FIT Biotech Oyjs human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the FIT Biotech Oyjs pipeline products
Reasons to buy
- Evaluate FIT Biotech Oyjs strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of FIT Biotech Oyj in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the FIT Biotech Oyjs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of FIT Biotech Oyj and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of FIT Biotech Oyj
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of FIT Biotech Oyj and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 3
list Of Figures 3
fit Biotech Oyj Snapshot 4
fit Biotech Oyj Overview 4
key Information 4
key Facts 4
fit Biotech Oyj - Research And Development Overview 5
key Therapeutic Areas 5
fit Biotech Oyj - Pipeline Review 7
pipeline Products By Stage Of Development 7
pipeline Products - Monotherapy 8
fit Biotech Oyj - Pipeline Products Glance 9
fit Biotech Oyj - Clinical Stage Pipeline Products 9
phase Ii Products/combination Treatment Modalities 9
FIT Biotech Oyj - Product Pipeline Review - 2014

2. phase I Products/combination Treatment Modalities 10
fit Biotech Oyj - Early Stage Pipeline Products 11
preclinical Products/combination Treatment Modalities 11
discovery Products/combination Treatment Modalities 12
fit Biotech Oyj - Drug Profiles 13
fit-06 13
product Description 13
mechanism Of Action 13
r&d Progress 13
gtu-nef 15
product Description 15
mechanism Of Action 15
r&d Progress 15
fp6 Tbvac 16
product Description 16
mechanism Of Action 16
r&d Progress 16
malaria Vaccine 17
product Description 17
mechanism Of Action 17
r&d Progress 17
vaccine For Dengue Fever 18
product Description 18
mechanism Of Action 18
r&d Progress 18
fit Biotech Oyj - Pipeline Analysis 19
fit Biotech Oyj - Pipeline Products By Target 19
fit Biotech Oyj - Pipeline Products By Route Of Administration 20
fit Biotech Oyj - Pipeline Products By Molecule Type 21
fit Biotech Oyj - Recent Pipeline Updates 22
fit Biotech Oyj - Dormant Projects 23
fit Biotech Oyj - Locations And Subsidiaries 24
head Office 24
appendix 25
methodology 25
coverage 25
secondary Research 25
primary Research 25
expert Panel Validation 25
contact Us 26
disclaimer 26
list Of Tables
fit Biotech Oyj, Key Information 4
fit Biotech Oyj, Key Facts 4
fit Biotech Oyj - Pipeline By Indication, 2014 6
fit Biotech Oyj - Pipeline By Stage Of Development, 2014 7
fit Biotech Oyj - Monotherapy Products In Pipeline, 2014 8
fit Biotech Oyj - Phase Ii, 2014 9
fit Biotech Oyj - Phase I, 2014 10
fit Biotech Oyj - Preclinical, 2014 11
fit Biotech Oyj - Discovery, 2014 12
fit Biotech Oyj - Pipeline By Target, 2014 19
fit Biotech Oyj - Pipeline By Route Of Administration, 2014 20
fit Biotech Oyj - Pipeline By Molecule Type, 2014 21
fit Biotech Oyj - Recent Pipeline Updates, 2014 22
fit Biotech Oyj - Dormant Developmental Projects,2014 23
list Of Figures
fit Biotech Oyj - Pipeline By Top 10 Indication, 2014 6
fit Biotech Oyj - Pipeline By Stage Of Development, 2014 7
fit Biotech Oyj - Monotherapy Products In Pipeline, 2014 8
fit Biotech Oyj - Pipeline By Top 10 Route Of Administration, 2014 20
fit Biotech Oyj - Pipeline By Top 10 Molecule Type, 2014 21
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
FIT Biotech Oyj - Product Pipeline Review - 2014

3. informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
FIT Biotech Oyj - Product Pipeline Review - 2014